Page last updated: 2024-08-17

levodopa and Urinary Tract Diseases

levodopa has been researched along with Urinary Tract Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amboni, M; Barone, P; Chaudhuri, KR; Erro, R; Longo, K; Martinez-Martin, P; Moccia, M; Pellecchia, MT; Picillo, M; Santangelo, G; Vitale, C1
Berrocal-Izquierdo, N; Castrillo-Sanz, A; Martínez-Pueyo, A; Rodríguez-Vico, JS1
Budzianowska, A; Gołab-Janowska, M; Honczarenko, K1
Nielsen, KK; Stimpel, H; Werdelin, LM; Winge, K1
Nishizawa, T1
Ferrari, E1

Reviews

1 review(s) available for levodopa and Urinary Tract Diseases

ArticleYear
[Dopaminergic stimulation in the non-motor symptoms of Parkinson's disease].
    Revista de neurologia, 2010, Feb-08, Volume: 50 Suppl 2

    Topics: Autonomic Nervous System Diseases; Digestive System Diseases; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Levodopa; Mental Disorders; Parkinson Disease; REM Sleep Parasomnias; Sexual Dysfunction, Physiological; Sleep Apnea Syndromes; Urologic Diseases

2010

Trials

1 trial(s) available for levodopa and Urinary Tract Diseases

ArticleYear
Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Neurourology and urodynamics, 2004, Volume: 23, Issue:7

    Topics: Adult; Antiparkinson Agents; Disease Progression; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Sex Characteristics; Surveys and Questionnaires; Urinary Bladder Diseases; Urination Disorders; Urodynamics; Urologic Diseases

2004

Other Studies

4 other study(ies) available for levodopa and Urinary Tract Diseases

ArticleYear
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:3

    Topics: Aged; Antiparkinson Agents; Cohort Studies; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Predictive Value of Tests; Severity of Illness Index; Urologic Diseases

2015
[Autonomic disorders in Parkinson's disease].
    Annales Academiae Medicae Stetinensis, 2011, Volume: 57, Issue:1

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Causality; Comorbidity; Constipation; Deglutition Disorders; Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Incidence; Levodopa; Male; Middle Aged; Nocturia; Parkinson Disease; Severity of Illness Index; Sex Distribution; Sialorrhea; Statistics, Nonparametric; Urinary Incontinence; Urologic Diseases; Vomiting

2011
[Secondary hyperuricemia].
    Ryumachi. [Rheumatism], 1985, Volume: 25, Issue:4

    Topics: Cardiovascular Diseases; Diuretics; Endocrine System Diseases; Ethanol; Fructose; Gout; Hematologic Diseases; Humans; Levodopa; Nutritional Physiological Phenomena; Proteins; Purines; Uric Acid; Urologic Diseases

1985
[Problems in the administration of L-DOPA (author's transl)].
    Rivista di patologia nervosa e mentale, 1974, Volume: 95, Issue:4

    Topics: Cardiovascular Diseases; Drug Eruptions; Gastrointestinal Diseases; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Urologic Diseases; Vision Disorders

1974